Edoardo Biancalana

443 total citations
25 papers, 301 citations indexed

About

Edoardo Biancalana is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Epidemiology. According to data from OpenAlex, Edoardo Biancalana has authored 25 papers receiving a total of 301 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Molecular Biology and 5 papers in Epidemiology. Recurrent topics in Edoardo Biancalana's work include Diabetes Treatment and Management (6 papers), Diet and metabolism studies (4 papers) and Diabetes Management and Research (4 papers). Edoardo Biancalana is often cited by papers focused on Diabetes Treatment and Management (6 papers), Diet and metabolism studies (4 papers) and Diabetes Management and Research (4 papers). Edoardo Biancalana collaborates with scholars based in Italy, Australia and United States. Edoardo Biancalana's co-authors include Anna Solini, Alessandro Mengozzi, Domenico Tricò, Chiara Rossi, Marta Seghieri, Stefano Taddei, Livia Giannini, Rosa María Bruno, Angela Dardano and Lorenzo Ghiadoni and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, International Journal of Molecular Sciences and Environmental Research.

In The Last Decade

Edoardo Biancalana

21 papers receiving 296 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edoardo Biancalana Italy 10 119 88 63 51 46 25 301
Tianzhichao Hou China 9 53 0.4× 115 1.3× 44 0.7× 50 1.0× 35 0.8× 22 262
Hua Zhong China 10 33 0.3× 67 0.8× 50 0.8× 39 0.8× 49 1.1× 31 303
Jing Cheng China 11 182 1.5× 63 0.7× 81 1.3× 67 1.3× 58 1.3× 25 316
Barry Toole United Kingdom 8 88 0.7× 97 1.1× 27 0.4× 47 0.9× 95 2.1× 12 441
Guillaume Grzych France 11 39 0.3× 85 1.0× 117 1.9× 62 1.2× 46 1.0× 34 336
Hong-Da Lin Taiwan 13 196 1.6× 109 1.2× 32 0.5× 87 1.7× 107 2.3× 22 446
Teddy Tai Loy Lee China 11 131 1.1× 64 0.7× 35 0.6× 25 0.5× 58 1.3× 29 338
Valerie Arends United States 11 130 1.1× 84 1.0× 42 0.7× 34 0.7× 139 3.0× 20 379
Jaehyun Bae South Korea 11 115 1.0× 66 0.8× 82 1.3× 62 1.2× 67 1.5× 34 314
Xikang Fan China 10 42 0.4× 70 0.8× 52 0.8× 56 1.1× 21 0.5× 33 333

Countries citing papers authored by Edoardo Biancalana

Since Specialization
Citations

This map shows the geographic impact of Edoardo Biancalana's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edoardo Biancalana with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edoardo Biancalana more than expected).

Fields of papers citing papers by Edoardo Biancalana

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edoardo Biancalana. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edoardo Biancalana. The network helps show where Edoardo Biancalana may publish in the future.

Co-authorship network of co-authors of Edoardo Biancalana

This figure shows the co-authorship network connecting the top 25 collaborators of Edoardo Biancalana. A scholar is included among the top collaborators of Edoardo Biancalana based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edoardo Biancalana. Edoardo Biancalana is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bagni, Giacomo, Edoardo Biancalana, Danilo Malandrino, et al.. (2025). Epigenetics in autoimmune diseases: Unraveling the hidden regulators of immune dysregulation. Autoimmunity Reviews. 24(6). 103784–103784. 6 indexed citations
2.
Sota, Jurgen, Luciana Breda, Maria Pia Paroli, et al.. (2025). Tocilizumab effectiveness in paediatric non-infectious uveitis: data from the International AIDA Network Registries on ocular inflammatory disorders. British Journal of Ophthalmology. 109(10). 1151–1154.
3.
Bond, Milena, Alessandra Bettiol, Giorgio Trivioli, et al.. (2025). Predictors of remission and relapse in retroperitoneal fibrosis. Journal of Internal Medicine. 298(5). 438–449.
4.
5.
Mastrolia, Maria Vincenza, et al.. (2024). Challenges and opportunities in transitional care process in Behçet’s syndrome. Frontiers in Medicine. 11. 1456063–1456063.
6.
Lopalco, Giuseppe, Vincenzo Venerito, Luca Cantarini, et al.. (2024). Exploring relief for Behçet’s disease refractory oral ulcers: a comparison of TNF inhibitors versus apremilast. Lara D. Veeken. 64(3). 1302–1308. 3 indexed citations
7.
Biancalana, Edoardo, Chiara Rossi, Francesco Raggi, et al.. (2023). Empagliflozin and Renal Sodium-Hydrogen Exchange in Healthy Subjects. The Journal of Clinical Endocrinology & Metabolism. 108(8). e567–e573. 9 indexed citations
8.
Biancalana, Edoardo, Giovanni Ceccarini, Silvia Magno, et al.. (2023). Canagliflozin on top of dual renin-angiotensin system blockade in a woman with partial acquired lipodystrophy, type 2 diabetes and severely proteinuric chronic kidney disease: a case report. Frontiers in Endocrinology. 14. 1172468–1172468. 1 indexed citations
9.
Rossi, Chiara, A Salvati, Daniela Campani, et al.. (2022). The P2X7R-NLRP3 and AIM2 Inflammasome Platforms Mark the Complexity/Severity of Viral or Metabolic Liver Damage. International Journal of Molecular Sciences. 23(13). 7447–7447. 12 indexed citations
10.
Biancalana, Edoardo, et al.. (2022). Parameters influencing renal response to SGLT2 inhibitors and GLP1 receptor agonists in type 2 diabetes patients with preserved renal function: a comparative, prospective study. Journal of Endocrinological Investigation. 46(5). 991–999. 1 indexed citations
11.
Mengozzi, Alessandro, et al.. (2022). High exposure to phthalates is associated with HbA1c worsening in type 2 diabetes subjects with and without edentulism: a prospective pilot study. Diabetology & Metabolic Syndrome. 14(1). 100–100. 3 indexed citations
12.
Solini, Anna, Chiara Rossi, Edoardo Biancalana, et al.. (2021). Molecular Characterization of Peritoneal Involvement in Primary Colon and Ovary Neoplasm: The Possible Clinical Meaning of the P2X7 Receptor-Inflammasome Complex. European Surgical Research. 63(3). 114–122. 6 indexed citations
13.
Biancalana, Edoardo, et al.. (2021). Clinical and epigenetic determinants of edentulism in type 2 diabetic subjects referring to a tertiary center. Journal of Diabetes and its Complications. 35(5). 107910–107910. 2 indexed citations
14.
Copetti, Massimiliano, Edoardo Biancalana, Andrea Fontana, et al.. (2021). All-cause mortality prediction models in type 2 diabetes: applicability in the early stage of disease. Acta Diabetologica. 58(10). 1425–1428. 2 indexed citations
15.
Biancalana, Edoardo, Martina Chiriacò, Paolo Sciarrone, et al.. (2021). Remdesivir, Renal Function and Short-Term Clinical Outcomes in Elderly COVID-19 Pneumonia Patients: A Single-Centre Study. Clinical Interventions in Aging. Volume 16. 1037–1046. 9 indexed citations
16.
Mengozzi, Alessandro, Fabrizia Carli, Letizia Guiducci, et al.. (2020). SGLT2 inhibitors and thiazide enhance excretion of DEHP toxic metabolites in subjects with type 2 diabetes: A randomized clinical trial. Environmental Research. 192. 110316–110316. 12 indexed citations
17.
Biancalana, Edoardo, et al.. (2020). Phenotyping individuals with newly-diagnosed type 2 diabetes at risk for all-cause mortality: a single centre observational, prospective study. Diabetology & Metabolic Syndrome. 12(1). 47–47. 4 indexed citations
18.
Biancalana, Edoardo, et al.. (2020). Short-term impact of COVID-19 lockdown on metabolic control of patients with well-controlled type 2 diabetes: a single-centre observational study. Acta Diabetologica. 58(4). 431–436. 55 indexed citations
19.
Solini, Anna, Marta Seghieri, Livia Giannini, et al.. (2019). The Effects of Dapagliflozin on Systemic and Renal Vascular Function Display an Epigenetic Signature. The Journal of Clinical Endocrinology & Metabolism. 104(10). 4253–4263. 72 indexed citations
20.
Mengozzi, Alessandro, Fabrizia Carli, Edoardo Biancalana, et al.. (2018). Phthalates Exposure as Determinant of Albuminuria in Subjects With Type 2 Diabetes: A Cross-Sectional Study. The Journal of Clinical Endocrinology & Metabolism. 104(5). 1491–1499. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tianzhichao Hou Breakdown of academic impact, for papers by Hua Zhong Breakdown of academic impact, for papers by Jing Cheng Breakdown of academic impact, for papers by Barry Toole Breakdown of academic impact, for papers by Guillaume Grzych Breakdown of academic impact, for papers by Hong-Da Lin Breakdown of academic impact, for papers by Teddy Tai Loy Lee Breakdown of academic impact, for papers by Valerie Arends Breakdown of academic impact, for papers by Jaehyun Bae Breakdown of academic impact, for papers by Xikang Fan
Rankless by CCL
2026